Biotech ETF Overview

With 15 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $17.24B. The average expense ratio is 0.77%. Biotech ETFs can be found in the following asset classes:

  • Equity

The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $8.15B in assets. In the last trailing year, the best performing Biotech ETF was the FBT at 2.06%. The most-recent ETF launched in the Biotech space was the Loncar China BioPharma ETF CHNA in 08/14/18.

Features and News

CNBC ETF Edge: Biotech Getting Sick?

How you should trade biotech ETFs.

ETF Report

 Sectors In Review: January 2019

November was mostly positive for sector ETFs.

ETF Report

 Sectors In Review: December 2018

Sector ETFs got clobbered in October.

ETF Report

5 Traits Of Successful Thematic ETFs

Thematic ETFs that capitalize on hot new trends can sizzle—or fizzle.

Daily ETF Watch

China Biotech ETF Launches

Latest ETF to come to market aims to offer unique access to an emerging hot sector only one other ETF focuses on today.

Features and News

Top Performing ETFs Of 2Q 2018

Health care, internet and oil products have performed well this year.

ETF Report

 Sectors In Review: July 2018

Sectors shined in May, with several seeing all their ETFs land in positive territory.

Features and News

Balchunas On Free ETFs & UFO Sighting

Bloomberg ETF analyst discusses what’s going on with ETFs in 2018. Analysis

The Stealth Marijuana Play In Your ETF

One in six U.S. ETFs has a connection to the marijuana industry.